✦ LIBER ✦

Rivaroxaban – an oral, direct Factor Xa inhibitor – has potential for the management of patients with heparin-induced thrombocytopenia

✍ Scribed by Jeanine M. Walenga; Margaret Prechel; Walter P. Jeske; Debra Hoppensteadt; Jyothi Maddineni; Omer Iqbal; Harry L. Messmore; Mamdouh Bakhos

Book ID: 108675911
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 209 KB
Volume: 143
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2008.07300.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BAY 59-7939: an oral, direct Factor Xa i

BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study

✍ A. G. G. TURPIE; W. D. FISHER; K. A. BAUER; L. M. KWONG; M. W. IRWIN; P. KÄLEBO; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB